Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Yves DauvilliersKarel ŠonkaRichard K BoganMarkku PartinenRafael Del Rio VillegasNancy Foldvary-SchaeferRoman SkowronskiAbby ChenJed BlackFranck SkobierandaMichael J ThorpyPublished in: CNS drugs (2022)
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy; https://clinicaltrials.gov/ct2/show/NCT03030599 ; clinicaltrials.gov identifier: NCT03030599.